Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
3.240
-0.080 (-2.41%)
Sep 4, 2026, 4:00 PM EDT - Market closed
Cellectis Market Cap
Cellectis has a market cap or net worth of $236.89 million as of September 4, 2026. Its market cap has increased by 26.48% in one year.
Market Cap
236.89M
Enterprise Value
149.07M
1-Year Change
26.48%
Ranking
Category
Stock Price
$3.24
ChartMarket Cap Chart
Since March 25, 2015, Cellectis's market cap has decreased from $1.34B to $236.89M, a decrease of -82.37%. That is a compound annual growth rate of -14.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 235.50M | -32.73% |
| Dec 31, 2025 | 350.10M | 169.72% |
| Dec 31, 2024 | 129.80M | -24.18% |
| Dec 29, 2023 | 171.20M | 78.89% |
| Dec 30, 2022 | 95.70M | -74.09% |
| Dec 31, 2021 | 369.30M | -67.88% |
| Dec 31, 2020 | 1.15B | 58.27% |
| Dec 31, 2019 | 726.40M | 2.87% |
| Dec 31, 2018 | 706.10M | -31.45% |
| Dec 29, 2017 | 1.03B | 72.73% |
| Dec 30, 2016 | 596.30M | -43.80% |
| Dec 31, 2015 | 1.06B | -21.04% |
| Mar 25, 2015 | 1.34B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Veraxa Biotech AG | 248.88M |
| Neumora Therapeutics | 246.14M |
| Eledon Pharmaceuticals | 245.65M |
| Compugen | 245.34M |
| Invivyd | 243.47M |
| Atrium Therapeutics | 242.73M |
| Adagene | 240.37M |
| Greenwich LifeSciences | 234.12M |